| Literature DB >> 21922427 |
Abstract
Phytotherapeutic pharmaceuticals and herbal medicinal products with its roots in classical phytotherapeutic medicine have a well-established role in otolaryngological therapy, especially for diseases of the upper airways and acute and chronic infections. A thorough selection and application could mean huge benefit for the patient, in particular in cases with contraindications, chemo- and antibiotic resistance or patient request. Besides, it might spare other medications. Phytotherapeutic pharmaceuticals must fulfil the same criteria of quality, effectiveness and harmlessness of evidence-based medicine like chemical pharmaceuticals, although they are often prescribed due to its well established or traditional based use. This review focuses on phytotherapeutic therapies well established within the European Community for otolaryngologic disease patterns by referring to clinical studies or meta-analysis.Entities:
Mesh:
Year: 2011 PMID: 21922427 PMCID: PMC3259400 DOI: 10.1007/s00405-011-1755-z
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503
Mode of preparation and administration form of phytotherapeutics
| Mode of preparation | Administration form | Therapeutical application and characterization |
|---|---|---|
| Aqueous extracts | ||
| Extracts with ethanol (tincture, fluid extracts) | Drops, inhalations, gargle solutions | Contain about 20–60% alcohol |
| Extracts with wine | Tonics, medicated wines | Contain about 16% alcohol |
| Spissum extracts | Baths, gels, soft gelatin capsules | Baths are in particular useful in early infections and should not be used when body temperature is increased |
| Alcoholic distillates | Contain essential oils, e.g. spirit of melissa | Contain 40–80% alcohol |
| Steam distillates | Essential oils | Most essential oils have to be diluted (e.g. in sunflower, peanut, almond oil 1/9) to avoid mucosal irritation or combined with a plant oil for skin preparations |
| Tea | Infusion | For small plant parts, thermolabile and volatile ingredients |
| Decoction | For not easily dissoluble plant parts and ingredients | |
| Maceration (cold preparation) | Plant parts where hot preparation would damage or release damaging ingredients | |
| Juices | Fresh-squeezed plant juices | Contain four times more active ingredients than tea |
| Creams, ointments, gels | Inunctions, fomentations | Selection and application according to skin moisture |
| Dry preparations (shredded, pulverized) | Tablets, dragees, pastilles, pellets, capsules | For systemic application |
Phytotherapeutic therapy of upper airway and deglutition tract infections
| Main mode of action | Phytotherapeutics | Characterization |
|---|---|---|
| Antiphlogistic | Chamomile flower, myrtle, thyme herb, sage leaf | α-Bisabolol and chamazulene in camomile inhibit the cyclooxygenase and lipoxygenase of arachidonic acid cascade |
| Antitussive-mucous releasing | Marshmallow leaf or root, ribwort plantain leaf, iceland moss thallus | Contain polysaccharides which swell with water |
| Antitussive-mucolytic (saponins) | Cowslip flower, thyme herb, english ivy leaf, mullein flower | Decrease mucous viscosity by decreasing the surface tension of water |
| Respiratory relieving, secretolytic | Mint oils (eucalyptus leaf and branch, peppermint leaf, mugo pine) | Central inhibitory effect by thermosensitive nerves |
| Cave: Kratschmer reflex in children | ||
| Menthol, camphor, 1,8-cineol | Depolarization of thermoreceptors by inhibition of calcium influx | |
| Antimicrobial | Garden nasturtium haulm, horseradish root | Contains mustard oils |
| Antipyretic | Lime flower, willow bark, european elder berry | The lacking acetyl group in salicin in elder avoids side effects of ASA |
| Immunomodulating | Echinacea root, chamomile flower | Stimulation of the unspecific cellular and humoral immune response |
| Cave: application duration, autoimmune and systemic diseases |
Discussed phytotherapeutic pharmaceuticals and their indication, administration form and dose
| Phytotherapeutic pharmaceutical | Indication | Administration form | Dose |
|---|---|---|---|
| Angocin®, REPHA GmbH Biologische Arzneimittel, Langenhagen, Germany | Phytotherapeutic pharmaceutical with antibacterial properties against grampositive and gramnegative strains, virostatic and antimycotic effects | Film tablet | 4–5 tablets 3–5 times per day, children (4–8 years) 2–3 tablets 3–5 times per day |
| Acute infections (e.g. acute pharyngotonsillitis, acute laryngitis, acute sinusitis) | |||
| Bronchipret®, Bionorica AG, Neumarkt, Germany | Acute and chronic bronchitis | Drops, syrup or film tablet | Drops: 40 drops 4 times per day, adolescents (12–18 years) 28 drops 4 times per day, children (6–11 years) 20 drops 4 times per day |
| Expectorant | |||
| Syrup: 5.4 ml 3 times per day, babies (−12 month) 1.1 ml 3 times per day, infants (−2 years) 2.2 ml 3 times per day, children (−6 years) 3.2 ml 3 times per day, children (−12 years) 4.3 ml 3 times per day | |||
| Tablets: 1 tablet 3 times per day | |||
| Contramutan® N, manufactured by A. Nettermann & Cie. GmbH, Cologne, Germany | Acute infectious of the upper airways (e.g. acute laryngopharyngitis) | Drops, syrup or tablet | Drops: 5–10 drops up to 12 times per day, children (6–12 years) 4–7 dops up to 12 times per day, children (1–6 years) 3-5 drops up to 12 times per day; after symptom relief intake is reduced to 3 times per day |
| Syrup: 15 ml every hour, children 5 ml every hour; after symptom relief intake is reduced to 3 times per day | |||
| Tablets: 1 tablet up to 12 times per day, children 1 tablet up to 6 times per day; after symptom relief intake is reduced to 1–3 times per day | |||
| Equisil® N, Dr. Gustav Klein GmbH & Co KG, Zell am Hamersbach, Germany | Intermediate cough state (productive and dry) | Syrup | 2.5 ml 3 times per day |
| Esberitox®, Schaper & Bruemmer GmbH & Co KG, Salzgitter, Germany | Acute infectious of the upper airways (e.g. acute laryngopharyngitis) | Drops, tablet | 50 drops or 3 tablets 3 times per day, babies 10 drops or 1 tablet once per day, children (−6 years) 15 drops or 1–2 tablets twice per day, children (−12 years) 25 drops or 2 tablets twice per day |
| GeloMyrtol® forte, G. Pohl Boskamp GmbH & Co KG, Hohenlockstadt, Germany | Acute and chronic rhinosinusitis | Gastro-resistant capsule | 1 capsule 3–4 times per day for acute infections, 1 capsule twice for chronic infections |
| Acute and chronic bronchitis | |||
| Postoperative convalescence | |||
| Pregnancy | |||
| Imupret®, Bionorica AG, Neumarkt, Germany | Chronic tonsillitis, tracheitis, adenoid hyperplasia | Dragee or drops | 2 dragees or 25 drops 5–6 times per day, children (−12 years) 1 dragee or 15 drops once per day, babies and infants 5–10 drops 5–6 times per day; after symptom relief intake is reduced to 3 times per day for 7 days |
| Lomaherpan®, Lomapharm Rudolf Lohmann GmbH KG, Emmerthal, Germany | Skin or mucosa infections with herpes simplex virus | Cream | 10–20 mg per cm2 2–4 times per day |
| Otikon Otic® solution, Healthy-On Ltd., Petach-Tikva, Israel | Acute otitis media | Ear drops | 5 drops 3 times per day |
| Prospan®, Engelhard Arzneimittel, Niederdorfelden, Germany | Productive cough | Drops, liquid, syrup, suppository, fizzy tablet or film tablet | Drops: 24 drops 3 times per day, children (4–10 years) 16 drops 3 times per day, children (1-year) 12 drops 3 times per day |
| Expectorant | |||
| Liquid: 5 ml 3 times per day | |||
| Syrup: 5–7.5 ml 3 times per day, children (6–9 years) 5 ml 3 times per day, children (1–5 years) 2.5 ml 3 times per day, children (−12 month) 1.5 ml twice per day | |||
| Suppositories: school children 1 supp. 3 times per day, babies and infants 1 supp. twice per day | |||
| Brausetabletten: 1 tablet twice per day, children (4–12 years) ½ tablet 3 times per day | |||
| Film tablets: 2 tablets 3 times per day | |||
| Sinupret®, Bionorica AG, Neumarkt, Germany | Acute and chronic rhinosinusitis, | Drops, liquitab®, dragee | 50 drops, 2 dragees or 2 liquitabs three times per day, children (6–12 years) 25 drops, 1 dragee or 1 liquitab per day, children (2–6 years) 15 drops per day |
| Acute and chronic bronchitis | |||
| Postoperative convalescence | |||
| Pregnancy | |||
| Tesalin® N, Zeller Medical AG, Romanshorn, Switzerland | Allergic rhinitis | Film tablets | 1 tablet 2–3 times per day |